Seed and early stage investments in exceptional technology and life sciences companies.

Partners:

Redalpine news

Portfolio Update: InSphero, MedMira and the Rebranding of Ebuzzing (09/10/2014)
We have witnessed an exciting start into the last quarter of the year with a lot of activity across our portfolio companies. Here are some highlights to keep you up-to-date: After taking top spot in the Swiss TOP 100 Startup Awards last month, InSphero (RAC I) has now won also the pan-European ACES award for [...] More.

Redalpine invests in Knip – Switzerland’s first fully digital insurance broker (06/10/2014)
Redalpine welcomes another truly disruptive company to its Capital II portfolio. Knip, Switzerland’s first fully digital insurance broker, offers an unrivalled user experience: Insurance policies overview and management combined with smart analysis to optimise your insurance portfolio and easy claims notifications – all conveniently packaged into a smartphone app. Insurance app Knip secures Series A [...] More.

Online-travel-pioneer Roland Zeller joins Redalpine to launch travel and tourism startup fund (01/10/2014)
Redalpine is pleased to announce that Swiss online-travel-pioneer Roland Zeller joins the team as a partner as of October 2014. Roland comes with a wealth of experience and looks back on an outstanding career in various positions in the travel industry. He was among the first in Switzerland to sell travel products online and later [...] More.

More More Redalpine news

Industry news

What investors say

"To evaluate the potential of a new idea requires experience and a clear understanding of the products and market dynamics. We trust in the team of Redalpine to master this challenge successfully."
Jürg Staub, General Partner, Reichmuth & Co, Privatbankiers
"Switzerland's future standard of living will largely depend on its ability to remain a player at the top of technological progress. Too many revolutionary ideas of our top universities have to emigrate to Silicon Valley to find early stage venture capital or remain in the drawers. Redalpine is active in this early stage where the need is most urgent and the potential gain the highest."
Dr. Henri B. Meier, former CFO Roche, Founder of HBM BioVentures

More More investor quotes

Connect with us

Subscribe to our news


Find us on Facebook


Find us on Twitter


Find us on LinkedIn